ArticleAmerican journal of cancer research2024

The salvage lenvatinib-based regimen provides survival benefit in patients with refractory metastatic colorectal cancer.

Yun-Chieh Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.